Orphan Drugs: Worldwide Orphan Medicinal Designation Workshop

Posted on

Orphan Druganaut Blog

Mark your calendars !!

Plan on attending a workshop on orphan product designation and grants organized by the following three regulatory agencies :

•   European Medicines Agency (EMA)

•   US Food and Drug Administration (FDA)

•   Japanese Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA).

The joint EMA/FDA/MHLW-PMDA Orphan Medicinal Product Workshop is scheduled for March 10, 2014, at the EMA, in London (UK). There is no registration fee for attending, but registration is required. One can register online. The meeting Agenda is available.

The purpose of the workshop is to provide information, about the EMA, FDA, and MHLW-PMDA regulatory agencies, requirements for orphan product designations, and information on grant programs available for the development of orphan products. The goal is to encourage and promote the development of new orphan products for rare diseases.

The workshop’s morning session will provide information about the EMA, FDA, and MHLW-PMDA…

View original post 217 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s